title: Prevention of VTE in patients having major orthopedic surgery.
abstract: Venous thromboembolism (VTE) is a serious risk after major orthopedic surgery (MOS) including total knee replacement, total hip replacement and hip fracture surgery. This risk can be reduced with several pharmacologic and mechanical prophylactic approaches, and the choice among them depends on their ability to reduce VTE with an acceptable increase in adverse events, especially major bleeding complications. Improvements in medical and surgical care have led to a progressive decrease in the risk of VTE after MOS with an estimated baseline risk with contemporary practice of approximately 4.3 % up to day 39 after surgery. Low-molecular-weight heparin is the most thoroughly studied thromboprophylactic agent following MOS and demonstrates good effectiveness with an acceptable rate of bleeding complications. Warfarin, rivaroxaban, dabigatran, and apixaban have all been studied in large trials in comparison with low-molecular-weight heparin and also show an acceptable benefit: risk ratio. Mechanical approaches including graduated compression stockings, intermittent pneumatic compression and venous foot pump also offer protection against VTE, but there is less evidence is available regarding their effectiveness and risks. Combination therapy consisting of an antithrombotic agent and mechanical device is probably more effective than either alone. The appropriate use of thromboprophylaxis after MOS results in reduced VTE with acceptable bleeding risks.
authors: University of Rochester Medical Center, Rochester, NY 14642, USA. charles_francis@urmc.rochester.edu
authors: Charles W
authors: CW
authors: Francis
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D019637:Orthopedic Procedures / Q000009:adverse effects*; D019106:Postoperative Hemorrhage / Q000188:drug therapy / Q000209:etiology; D012307:Risk Factors; D053828:Stockings, Compression; D054556:Venous Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants
references: J Bone Joint Surg Br. 2004 Jul;86(5):639-42
references: 15274256
references: Lancet. 1959 Dec 5;2(7110):981-9
references: 14445257
references: J Thromb Haemost. 2007 Dec;5(12):2368-75
references: 17868430
references: N Engl J Med. 2001 Nov 1;345(18):1298-304
references: 11794148
references: Int Orthop. 1996;20(6):367-9
references: 9049766
references: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD005258
references: 18843686
references: Anesthesiology. 2003 Sep;99(3):552-60; discussion 5A
references: 12960538
references: Acta Chir Scand. 1966 Jan-Feb;131(1):16-29
references: 5332064
references: J Bone Joint Surg Am. 2010 Mar;92(3):527-35
references: 20194309
references: Thromb Haemost. 2011 Apr;105(4):721-9
references: 21225098
references: J Arthroplasty. 2009 Jan;24(1):1-9
references: 18534438
references: J Arthroplasty. 2006 Feb;21(2):206-14
references: 16520208
references: N Engl J Med. 2008 Jun 26;358(26):2765-75
references: 18579811
references: Lancet. 2009 May 16;373(9676):1673-80
references: 19411100
references: N Engl J Med. 2008 Jun 26;358(26):2776-86
references: 18579812
references: N Engl J Med. 2000 Dec 14;343(24):1758-64
references: 11114314
references: Chest. 2012 Feb;141(2 Suppl):e1S-e23S
references: 22315262
references: Lancet. 2002 May 18;359(9319):1715-20
references: 12049858
references: JAMA. 1983 Nov 18;250(19):2649-54
references: 6355542
references: J Bone Joint Surg Am. 2010 Sep 15;92(12):2156-64
references: 20844157
references: Chest. 2012 Feb;141(2 Suppl):e278S-e325S
references: 22315265
references: Lancet. 2008 Jul 5;372(9632):31-9
references: 18582928
references: Acta Orthop Scand. 1976 Jun;47(3):276-82
references: 782146
references: Lancet. 2000 Apr 15;355(9212):1295-302
references: 10776741
references: Lancet. 2007 Sep 15;370(9591):949-56
references: 17869635
references: J Orthop Surg (Hong Kong). 2009 Apr;17(1):1-5
references: 19398783
references: J Bone Joint Surg Am. 1998 Aug;80(8):1158-66
references: 9730125
references: J Thromb Haemost. 2007 Nov;5(11):2178-85
references: 17764540
references: Lancet. 2010 Mar 6;375(9717):807-15
references: 20206776
references: N Engl J Med. 2009 Aug 6;361(6):594-604
references: 19657123
references: BMJ. 2010 Jan 27;340:c95
references: 20106897
references: Thromb Haemost. 2003 Sep;90(3):446-55
references: 12958614
references: Lancet. 2000 Jul 15;356(9225):247; author reply 250-1
references: 10963215
references: Chest. 2012 Feb;141(2 Suppl):e185S-e194S
references: 22315260
references: N Engl J Med. 2010 Dec 23;363(26):2487-98
references: 21175312
references: N Engl J Med. 2001 Nov 1;345(18):1305-10
references: 11794149
references: Lancet. 2002 May 18;359(9319):1721-6
references: 12049860
references: J Bone Joint Surg Br. 1999 Jul;81(4):654-9
references: 10463739
references: Acta Chir Scand. 1965 May;129:500-8
references: 14296582